As of 2026-03-25, the Relative Valuation of BetterLife Pharma Inc (BETR.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 CAD, the upside of BetterLife Pharma Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-03-19 | -5.75 |
| 2026-03-17 | -6.16 |
| 2026-03-16 | -5.75 |
| 2026-03-12 | -5.75 |
| 2026-03-11 | -6.16 |
| 2026-03-10 | -5.75 |
| 2026-03-09 | -5.34 |
| 2026-03-06 | -6.98 |
| 2026-03-05 | -5.75 |
| 2026-03-04 | -4.92 |
| 2026-02-27 | -4.92 |
| 2026-02-26 | -5.34 |
| 2026-02-25 | -4.92 |
| 2026-02-24 | -4.10 |
| 2026-02-19 | -4.51 |
| 2026-02-17 | -4.51 |
| 2026-02-11 | -4.51 |
| 2026-02-09 | -4.92 |
| 2026-02-06 | -4.92 |
| 2026-02-04 | -4.51 |
| 2026-02-03 | -4.51 |
| 2026-02-02 | -4.51 |
| 2026-01-30 | -4.10 |
| 2026-01-29 | -4.10 |
| 2026-01-28 | -4.10 |
| 2026-01-27 | -4.10 |
| 2026-01-23 | -4.10 |
| 2026-01-22 | -3.69 |
| 2026-01-19 | -4.10 |
| 2026-01-16 | -3.69 |
| 2026-01-15 | -3.69 |
| 2026-01-14 | -3.69 |
| 2026-01-13 | -3.69 |
| 2026-01-09 | -4.10 |
| 2026-01-08 | -4.10 |
| 2026-01-07 | -3.28 |
| 2026-01-06 | -4.10 |
| 2026-01-05 | -3.69 |
| 2026-01-02 | -3.69 |
| 2025-12-30 | -4.10 |
| 2025-12-29 | -3.69 |
| 2025-12-23 | -3.69 |
| 2025-12-22 | -4.10 |